Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

For Arena, Belviq Refills Are Becoming Key
Seeking Alpha
Saturday, September 28, 2013 - 10:39am
tags:
Belviq, Arena Pharmaceuticals
The Rosen Law Firm Announces Investigation of Shareholder Securities Claims Against Prosensa Holding NV – RNA
Yahoo/BusinessWire
Saturday, September 28, 2013 - 10:38am
tags:
Prosensa, lawsuits
Does a Lack of Interest Tell You This Biotech Has Limited Upside?
Motley Fool
Saturday, September 28, 2013 - 10:36am
tags:
Clovis Oncology
Jazz Pharmaceuticals Stares At Generic Threat, Thrives
investors.com
Saturday, September 28, 2013 - 10:34am
tags:
Jazz Pharmaceuticals, generics
Actos jury says Takeda failed at safety warnings, but judge tosses $1.7M verdict
Fierce Pharma
Friday, September 27, 2013 - 11:55am
tags:
Actos, Takeda, bladder cancer, diabetes
FDA officials take to social media outlet Twitter to spread a message about its new mobile medical application rules: regulation will be passive
Mass Device
Friday, September 27, 2013 - 11:52am
tags:
devices, FDA, twitter, social media, mHealth, mobile medical apps
ArQule up on hope for lung cancer drug revival
Reuters
Friday, September 27, 2013 - 11:51am
tags:
Arqule, tivantinib, Daiichi Sankyo, lung cancer
Inotek snags $21M for PhII glaucoma drops
Fierce Biotech
Friday, September 27, 2013 - 11:48am
tags:
Inotek, glaucoma
Forget The Apology: Japan To Raid Novartis Offices Over Diovan Scandal
Pharmalot
Friday, September 27, 2013 - 11:47am
tags:
Japan, Novartis, Diovan
Merck KGaA overhauls pharma management to boost growth
Fierce Pharma
Friday, September 27, 2013 - 11:46am
tags:
restructuring, Merck KGaA
These Drug Makers Are Still Standing Strong
Seeking Alpha
Friday, September 27, 2013 - 11:45am
tags:
Bristol-Myers Squibb, Pfizer, JNJ, Eliquis, Xarelto, bloodthinners
KKR to Buy Panasonic Health Care Unit for $1.67 Billion
Bloomberg
Friday, September 27, 2013 - 11:44am
tags:
KKR, M&A, Panasonic, devices
Medtronic’s Artificial Pancreas Approved for U.S. Diabetics
Bloomberg
Friday, September 27, 2013 - 11:42am
tags:
Medtronic, diabetes, FDA, artificial pancreas, devices, MiniMed 530G
Nektar Plummets After Pain Drug Misses Goals of Mid-Stage Study
Bloomberg
Friday, September 27, 2013 - 11:41am
tags:
Nektar, NKTR-181, chronic pain
Arena Sales - Pacing Along Modestly
Seeking Alpha
Friday, September 27, 2013 - 11:39am
tags:
Arena Pharmaceuticals, Eisai, Belviq
NeoStem Unfazed By Hiccup Over Its AMR-001 Cardiovascular Stem Cell Treatment
Forbes
Friday, September 27, 2013 - 11:38am
tags:
AMR-001, NeoStem
US approves Mylan's purchase of Strides unit, with conditions
Reuters
Friday, September 27, 2013 - 9:21am
tags:
Mylan, M&A, Strides Arcolab
Endocyte says Doxil supply interruption will not affect PROCEED trial
The Fly on the Wall
Friday, September 27, 2013 - 9:11am
tags:
Endocyte, Doxil, JNJ, drug shortages, vintafolide, clinical trials, etarfolatide, ovarian cancer
Will Teva Recover From Its Downfall?
Motley Fool
Friday, September 27, 2013 - 9:00am
tags:
Teva, earnings
Novartis reports new data for Lucentis backs transformational efficacy
The Fly on the Wall
Friday, September 27, 2013 - 8:59am
tags:
Novartis, Lucentis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.